Incidence of and Factors Associated with Hypokalemia During Sulbactam/Ampicillin Therapy: A Retrospective Observational Study
Background: The antimicrobial agent sulbactam/ampicillin (SBT/ABPC) is used to treat a wide range of infections; however, hypokalemia has recently attracted attention as an adverse event of SBT/ABPC. Risk factors for this condition have not been fully characterized, and preventive strategies remain unclear. Objective: To investigate the incidence of hypokalemia and identify factors associated with its occurrence during sulbactam/ampicillin therapy. Methods: This single-center retrospective observational study used routinely collected electronic medical record data from hospitalized patients aged ≥ 20 years without hypokalemia at the initiation of SBT/ABPC therapy who received SBT/ABPC for >2 consecutive days at a hospital in Japan between January 1, 2022, and December 31, 2024. Patients undergoing hemodialysis, those with hypokalemia at the initiation of SBT/ABPC therapy, and those lacking the required laboratory or body weight data were excluded. The primary endpoint was the identification of factors associated with hypokalemia during SBT/ABPC therapy. Results: Of the 269 patients who received SBT/ABPC during the study period, 182 were included in the analysis. Hypokalemia occurred in 39 patients (21.4%), of whom 6 had a nadir serum potassium concentration ≤ 3.0 mEq/L. The median time to onset was 4 days (range, 2-13 days). Survival classification and regression tree analysis identified a baseline serum potassium level of ≤3.9 mEq/L ( P < .001) and age >75 years ( P = .008) as factors associated with the occurrence of hypokalemia. Conclusion and relevance: Close monitoring for hypokalemia may be warranted in patients aged > 75 years with a baseline serum potassium level of ≤3.9 mEq/L. In such patients, serum potassium measurement within the first several days after initiation of SBT/ABPC therapy, particularly around days 4 to 5, should be considered.
Authors
- Kazutaka Oda (ORCID: https://orcid.org/0000-0003-0693-1896)
- Kazutaka Uchida (ORCID: https://orcid.org/0000-0003-4780-9598)
- Yoshihiro Nakagawa
- Kenshiro Higashi
Institutions
- Kumamoto City Hospital (JP)
- Kumamoto University Hospital (JP)
- Kumamoto Shinto General Hospital (JP)
- Kumamoto University (JP)
Publication Details
- Journal
- Hospital Pharmacy
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1177/00185787261502964
- Primary Topic
- Potassium and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00